0

Liver Disease Collection
 81-100 of 964 Articles
Brief Communications |  16 April 2002
Severe Hepatotoxicity Associated with the Dietary Supplement LipoKinetix
Joya T. Favreau, MD; Mina L. Ryu, MD; Glenn Braunstein, MD; et al.
Ann Intern Med. 2002;136(8):590-595. doi:10.7326/0003-4819-136-8-200204160-00008
Brief Communications |  19 March 2002
Mixed Hepatocellular–Cholestatic Liver Injury after Pioglitazone Therapy
Louis D. May, MD; Jay H. Lefkowitch, MD; Michael T. Kram, MD; et al.
Ann Intern Med. 2002;136(6):449-452. doi:10.7326/0003-4819-136-6-200203190-00008
Editorials |  19 March 2002
“Did This Drug Cause My Patient's Hepatitis?” and Related Questions
David W. Nierenberg, MD
Ann Intern Med. 2002;136(6):480-483. doi:10.7326/0003-4819-136-6-200203190-00013
Brief Communications |  19 February 2002
Surprisingly Small Effect of Antiviral Treatment in Patients with Hepatitis C
Yngve Falck-Ytter, MD; Hemangi Kale, MD; Kevin D. Mullen, MD; et al.
Ann Intern Med. 2002;136(4):288-292. doi:10.7326/0003-4819-136-4-200202190-00008
Brief Communications |  15 May 2001
Effects of Long-Term Postoperative Interferon-α Therapy on Intrahepatic Recurrence after Resection of Hepatitis C Virus–Related Hepatocellular Carcinoma: A Randomized, Controlled Trial
Shoji Kubo, MD; Shuhei Nishiguchi, MD; Kazuhiro Hirohashi, MD; et al.
Ann Intern Med. 2001;134(10):963-967. doi:10.7326/0003-4819-134-10-200105150-00010
Brief Communications |  16 January 2001 FREE
The Relationship of Acute Transfusion-Associated Hepatitis to the Development of Cirrhosis in the Presence of Alcohol Abuse
D. Robert Harris, PhD; René Gonin, PhD; Harvey J. Alter, MD; et al.
Ann Intern Med. 2001;134(2):120-124. doi:10.7326/0003-4819-134-2-200101160-00012
Brief Communications |  19 December 2000
Severe Liver Injury after Treatment with the Leukotriene Receptor Antagonist Zafirlukast
John F. Reinus, MD; Seth Persky, MD; Jill S. Burkiewicz, PharmD; et al.
Ann Intern Med. 2000;133(12):964-968. doi:10.7326/0003-4819-133-12-200012190-00011
Brief Communications |  5 December 2000
Fatal Hepatorenal Failure Associated with Hydrazine Sulfate
Mark I. Hainer, DO; Naoky Tsai, MD; Steven T. Komura, MD; et al.
Ann Intern Med. 2000;133(11):877-880. doi:10.7326/0003-4819-133-11-200012050-00011
Editorials |  5 December 2000
Hydrazine, Cancer, the Internet, Isoniazid, and the Liver
Martin Black, MD; Hamid Hussain, MD
Ann Intern Med. 2000;133(11):911-913. doi:10.7326/0003-4819-133-11-200012050-00016
Articles |  7 November 2000
Watchful Waiting with Periodic Liver Biopsy versus Immediate Empirical Therapy for Histologically Mild Chronic Hepatitis C: A Cost-Effectiveness Analysis
John B. Wong, MD; Raymond S. Koff, MD
Ann Intern Med. 2000;133(9):665-675. doi:10.7326/0003-4819-133-9-200011070-00008
Brief Communications |  7 November 2000
Methylene Blue Improves the Hepatopulmonary Syndrome
Peter Schenk, MD; Christian Madl, MD; Shahrzad Rezaie-Majd, MD; et al.
Ann Intern Med. 2000;133(9):701-706. doi:10.7326/0003-4819-133-9-200011070-00012
Editorials |  7 November 2000
Methylene Blue and Cirrhosis: Pathophysiologic Insights, Therapeutic Dilemmas
Michael B. Fallon, MD
Ann Intern Med. 2000;133(9):738-740. doi:10.7326/0003-4819-133-9-200011070-00016
Articles |  5 September 2000
The Effect of HFE Genotypes on Measurements of Iron Overload in Patients Attending a Health Appraisal Clinic
Ernest Beutler, MD; Vincent Felitti, MD; Terri Gelbart, BS; et al.
Ann Intern Med. 2000;133(5):329-337. doi:10.7326/0003-4819-133-5-200009050-00008
Articles |  15 August 2000
Efficacy and Safety of Troglitazone in the Treatment of Lipodystrophy Syndromes
Elif Arioglu, MD; Jennifer Duncan-Morin, RN; Nancy Sebring, RD; et al.
Ann Intern Med. 2000;133(4):263-274. doi:10.7326/0003-4819-133-4-200008150-00009
Brief Communications |  1 August 2000 FREE
Lactic Acidosis and Hepatic Steatosis Associated with Use of Stavudine: Report of Four Cases
Kirk D. Miller, MD; Miriam Cameron, MD; Lauren V. Wood, MD; et al.
Ann Intern Med. 2000;133(3):192-196. doi:10.7326/0003-4819-133-3-200008010-00010
Reviews |  2 May 2000
Chronic Hepatitis B Virus Infection: Treatment Strategies for the Next Millennium
Arshad H. Malik, MD; William M. Lee, MD
Ann Intern Med. 2000;132(9):723-731. doi:10.7326/0003-4819-132-9-200005020-00007
Articles |  4 April 2000
Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy
Yasushi Shiratori, MD; Fumio Imazeki, MD; Mitsuhiko Moriyama, MD; et al.
Ann Intern Med. 2000;132(7):517-524. doi:10.7326/0003-4819-132-7-200004040-00002
Articles |  4 April 2000
Prevalence of Liver Disease and Contributing Factors in Patients Receiving Home Parenteral Nutrition for Permanent Intestinal Failure
Maryan Cavicchi, MD; Philippe Beau, MD; Pascal Crenn, MD; et al.
Ann Intern Med. 2000;132(7):525-532. doi:10.7326/0003-4819-132-7-200004040-00003
Articles |  18 January 2000
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
Stefano Bellentani, MD, PhD; Gioconda Saccoccio, MD; Flora Masutti, MD; et al.
Ann Intern Med. 2000;132(2):112-117. doi:10.7326/0003-4819-132-2-200001180-00004
Brief Communications |  18 January 2000
Hepatic Failure in a Patient Taking Rosiglitazone
Lisa M. Forman, MD; David A. Simmons, MD; Robert H. Diamond, MD
Ann Intern Med. 2000;132(2):118-121. doi:10.7326/0003-4819-132-2-200001180-00005
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)